PIRAMAL CRITICAL FDA Approval ANDA 206681

ANDA 206681

PIRAMAL CRITICAL

FDA Drug Application

Application #206681

Application Sponsors

ANDA 206681PIRAMAL CRITICAL

Marketing Status

Prescription001
Prescription002

Application Products

001INJECTABLE;INJECTIONEQ 1GM BASE/VIAL0OXACILLIN SODIUMOXACILLIN SODIUM
002INJECTABLE;INJECTIONEQ 2GM BASE/VIAL0OXACILLIN SODIUMOXACILLIN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2017-09-11STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP
002PrescriptionAP

CDER Filings

PIRAMAL CRITICAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206681
            [companyName] => PIRAMAL CRITICAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"OXACILLIN SODIUM","activeIngredients":"OXACILLIN SODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OXACILLIN SODIUM","activeIngredients":"OXACILLIN SODIUM","strength":"EQ 2GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/11\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-09-11
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.